Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy

Conditions:   Grade I Meningioma;   Grade II Meningioma;   Grade III Meningioma;   Recurrent Meningioma;   Unresectable Meningioma Interventions:   Radiation: Gallium Ga 68-DOTATATE;   Drug: Lutetium Lu 177 Dotatate;   Procedure: Magnetic Resonance Imaging;   Procedure: Positron Emission Tomography;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration Sponsors:   Mayo Clinic;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials